Table 5.
Outcome measures
|
Sample groups
|
Baseline
|
One-month
|
P value
|
Effectiveness size
|
Power
|
Item 1 | VR (n = 23), mean (SD) | 4.29 (1.27) | 4.13 (1.29) | 0.62 | 0.0677 | 0.9998 |
TAU (n = 17), mean (SD) | 3.71 (1.52) | 4.12 (1.54) | 0.454 | 0.125 | 0.9784 | |
VR vs TAU1 | - | - | 0.924 | 0.0155 | 0.9995 | |
Item 2 | VR (n = 23), mean (SD) | 32.17 (4.13) | 31.78 (4.31) | 0.531 | 0.0833 | 0.9996 |
TAU (n = 17), mean (SD) | 31.14 (3.73) | 32.83 (4.75) | 0.147 | 0.237 | 0.7974 | |
VR vs TAU1 | - | - | 0.367 | 0.143 | 0.9717 | |
Item 3 | VR (n = 23), mean (SD) | 5.53 (0.71) | 5.08 (10.4) | 0.152 | 0.213 | 0.9575 |
TAU (n = 17), mean (SD) | 5.43 (10.3) | 5.47 (0.80) | 0.918 | 0.0198 | 0.9992 | |
VR vs TAU1 | - | - | 0.286 | 0.187 | 0.9236 | |
Item 4 | VR (n = 23), mean (SD) | 4.79 (1.07) | 4.78 (1.24) | 0.909 | 0.0157 | 1 |
TAU (n = 17), mean (SD) | 5.14 (1.03) | 5.06 (1.03) | 0.725 | 0.0619 | 0.9964 | |
VR vs TAU1 | - | - | 0.547 | 0.1 | 0.9912 | |
Item 5 | VR (n = 23), mean (SD) | 5.35 (0.88) | 5.09 (1.08) | 0.375 | 0.129 | 0.9974 |
TAU (n = 17), mean (SD) | 4.71 (1.74) | 5.06 (1.43) | 0.628 | 0.0864 | 0.9925 | |
VR vs TAU1 | - | - | 0.692 | 0.0678 | 0.9967 | |
Item 6 | VR (n = 23), mean (SD) | 5.62 (0.70) | 5.30 (0.97) | 0.216 | 0.192 | 0.9768 |
TAU (n = 17), mean (SD) | 5.71 (0.56) | 5.59 (0.71) | 0.714 | 0.0773 | 0.9943 | |
VR vs TAU1 | - | - | 0.359 | 0.166 | 0.9513 | |
Item 7 | VR (n = 23), mean (SD) | 4.88 (0.98) | 4.43 (1.34) | 0.251 | 0.157 | 0.9927 |
TAU (n = 17), mean (SD) | 4.29 (0.90) | 4.35 (0.86) | 0.86 | 0.0306 | 0.9988 | |
VR vs TAU1 | - | - | 0.753 | 0.0517 | 0.9981 | |
Item 8 | VR (n = 23), mean (SD) | 5.06 (1.37) | 5.17 (1.11) | 0.981 | 0.0036 | 1 |
TAU (n = 17), mean (SD) | 4.29 (1.79) | 4.06 (1.60) | 0.567 | 0.095 | 0.9904 | |
VR vs TAU1 | - | - | 0.023 | 0.375 | 0.2722 | |
Item 9 | VR (n = 23), mean (SD) | 5.09 (1.22) | 5.13 (1.14) | 0.987 | 0.0024 | 1 |
TAU (n = 17), mean (SD) | 3.71 (1.79) | 4.18 (1.51) | 0.445 | 0.126 | 0.9778 | |
VR vs TAU1 | - | - | 0.04 | 0.339 | 0.4144 |
Virtual reality vs treatment as usual comparison at one-month.
VR: Virtual reality; TAU: Treatment as usual.